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Dr G. Patrick Clagett (Dallas, Tex). Would you recommend
primary amputation in a patient who is functionally dependent and
has other markers for poor outcome such as increased P III score
and elevated CRP as we have heard from other papers this morn-
ing?
DrCrawford. I think that the impetus for this data or the way
that we would envision that this data would be used is that it would
not be a determining factor, or the ultimate factor in making that
decision. That decision needs to be made along with other clinical
factors. But I think it gives you data to back up not performing a
lower extremity bypass procedure if you decide to do that.
DrHasanDosluoglu (Buffalo, NY). I would like to point out
a weakness that I can see with this analysis. As you know, one of the
worst subjective parameters to collect in the NSQIP database is
the partially dependent, and dependent status. Actually you have
grouped partially dependent and dependent patients into one
group. When we were trying to subclassify ASA 3 patients who
underwent revascularization, which came out in the Journal of
Vascular Surgery last year, we struggled with the concept. The easy
thing to do was to actually look at the NSQIP, which I am from the
VA so which would be easy. We decided not to do that at the time
because of that unreliability and the fact that very few people – in
your series it is combined 18% – were in dependent and partially
dependent category. So, I do not know how it is going to really
help to differentiate risks in those patients in a meaningful manner.
We suggested that we should look at functional capacity rather
than just independent/dependent which is very, very subjective.
Dr Crawford. I think that the paper that you are alluding to,
has correctly identified that the categorization of patients by the
American Society of Anesthesiology is very subjective and there-
fore not particularly useful to classify vascular surgery patients.
There is subjectivity between different observers, even trained
anesthesiologists, which is why you went to the preoperative
variables that are in the NSQIP database and that is turned out to
be a better predictor of the outcomes. I think that if you see that
the dependent functional status determination as perhaps incon-
sistent and also subjective, that is one of the reasons we tried to
combine it with other preoperative variables, just like it was done in
the report that you are alluding to, to come up with high-risk
composites. So the odds of most of our complications and death
are increased by two- to threefold, if you look at it across the board,
by the addition of dependent functional status alone. It is really
when you start to add up other preoperative known variables that
are very easily obtained by clinicians before an operation that those
numbers start to stack up, and those numbers can be objectively
recorded before any procedure.
Dr JohnRicotta (Washington, DC). I wanted to follow onDr
Clagett’s question. I understand that I am asking you to speculate.
We have had a morning full of papers talking about prediction, and
we are in a socioeconomic situation where these data are either
going to have to be used or they are going to be no more than an
intellectual curiosity. Where are we going to go with these data in
terms of making some hard health care decisions? How comfort-
able are you with the data? What are some of the problems? Please
speculate on what the practical application of your conclusions,
because I think it highly likely that there data or similar data will be
used to guide health care policy decisions.
Dr Crawford. I think that that one can safely look at theimmediately should alert the clinician that this patient probably is
at increased risk for complications. If to that you add other known
variables, you come up with higher numbers. I think that what it
does is it adds data to a situation in which you are trying to justify
not performing one of these procedures. And that is the level to
which I am comfortable putting a practical application to this data
at this point.
Dr Daniel Clair (Cleveland, Ohio). This is probably a bit of
heresy, but the NSQIP data that you were evaluating does not
make a lot of sense, and I wonder about basing valid conclusions
on data that is questionable.
First, in this group of patients who are dependent, more than
a third of them had elective bypass procedures done for claudica-
tion, which I have some concern about. In addition, your overall
incidence of myocardial infarct – and if I am incorrect, please
correct me – was less than 10% in this patient population as well.
Those two points in particular are very troubling to me in terms of
utilizing this data and generalizing the conclusions that you are
making from them. I am just asking you to comment on both of
those things.
Dr Crawford. I do not know what data you are referring to
when you talk about the incidence of myocardial infarction and
how that invalidates conclusions from this report.
Dr Clair. It is simply that the incidence of coronary artery
disease in this patient population is usually much higher. You have
a much lower incidence documented in this patient population.
And the other is if there is a third of these patients who are
functionally dependent, who are having bypass grafting for claudi-
cation for noncritical limb ischemia? That makes me concerned
about the validity of the data that you are evaluating.
Dr LaMuraglia. The answer to that is that this data reflects
patients treated in a variety of institutions and that the data was
captured prospectively and has been validated. This is not data
from a clinical trial, but reflects every day practice. If you want to
look at patients who may have had some perioperative EKG
changes, it was up to the clinician to follow that up and try to
determine whether or not they had a myocardial infarction based
on their individual practice. There was no routine evaluation of
CPK and troponins.
The other issue you bring up is the number of patients
operated on with claudication who are not totally functionally
independent. This data is a reflection of cases done in academic
centers and in community hospitals and is a reflection of current
practice. These are not patients screened to meet a set of criteria
that are chosen for a prospective study and have inclusion/exclu-
sion criteria.
Dr Michael Conte (San Francisco, Calif). We have heard
three papers this morning trying to predict the outcomes of
patients getting lower extremity bypass and as coauthor of two of
these, I wanted to make two quick comments.
One is in follow-up to Dr Ricotta’s comment. All three of
these reports are retrospective analyses based on patients who
already had a procedure (bypass surgery) selected for them. We
should be very careful not to over-interpret these models to make
predictions, until they have been prospectively validated in all-
comers.
The second comment I would like to make is that we should
not just be thinking about the high-risk group in terms of their
suitability for revascularization. Rather the more relevant question
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outcome for these patients? Perhaps more intensive medical man-
agement in preparation for surgery, more intensive statin therapy
to lower their inflammatory state, etc. In other words, we should
be looking at these data to identify opportunities to improve the
outcomes from revascularization, not just to be nihilists.
DrWilliam Fry (Roanoke, Va). The details of the prospectivementioned in the discussion of the paper. When you show that
there is a 200-fold increase in risk in a certain group, health insurers
and legislators could use this information to deny care to these
groups, if we do not say something about how the data is incom-
plete. Have you looked at how to accomplish this goal?
Dr Crawford. I think we definitely need to validate these data
prospectively and that is why I was hesitant to make any furtheranalysis that needs to be done as a result of this study must be recommendations outside of what I did.
